🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This three-part study will evaluate the pharmacokinetics and bioavailabilit...
Status
Completed
Location
Multiple Locations
Start Date
2012-07
Trial ID
NCT01654211
Treatments Being Tested
The present study is a randomized clinical trial, with the approval of the ...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-20
Trial ID
NCT04521400
Treatments Being Tested
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
1. To investigate the relative bioavailability (BA) of improved tablet form...
Status
Completed
Location
Multiple Locations
Start Date
2005-06
Trial ID
NCT02259868
Treatments Being Tested
This is a drug-drug interaction study to assess the effects of a single dos...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2021-07-15
Trial ID
NCT04962230
Treatments Being Tested
The primary objective was to explore the relative bioavailability of increa...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT02253927
Treatments Being Tested
The purpose of this study is to see if it is safe to give saquinavir-SGC (S...
Status
Completed
Location
Los Angeles County - USC Med Ctr
Start Date
TBD
Trial ID
NCT00000920
Treatments Being Tested
CCTG 590 is a open-label study to evaluate the impact of therapy intensific...
Status
Completed
Location
University Southern California
Start Date
2008-10-20
Trial ID
NCT00925756
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ...
Status
Completed
Location
Yarosslavl Clinical Hospital #3
Start Date
2019-06-06
Trial ID
NCT04268472